Wegovy and Ozempic both contain the same active ingredient: semaglutide. The difference is not the molecule it’s how each product is authorised and used in practice. In the UK, Wegovy is positioned for weight management, while Ozempic is authorised for type 2 diabetes. This guide explains the differences that matter (indications, dose structures, access, and safety), without hype.

If you’re new to the medication, start with What is Wegovy? and How Wegovy works for weight loss.

Table of Contents

Quick answer (1 minute)

In most cases:

Wegovy is the semaglutide product intended for weight management pathways.
Ozempic is the semaglutide product authorised for type 2 diabetes management.
They have different dose structures and prescribing context, even though the ingredient is the same.

Key takeaway:

Same active ingredient (semaglutide), different product authorisation + dosing formats + access pathways.

What Wegovy is (context)

Wegovy is a prescription weight-loss injection used for weight loss and weight maintenance alongside a reduced-calorie diet and increased physical activity. It is usually taken once weekly, and doses are increased gradually to improve tolerability.

See the full overview in the Wegovy (semaglutide) weight loss injection hub.

What Ozempic is (context)

Ozempic is a prescription injection containing semaglutide that is authorised for type 2 diabetes. While people may notice weight change on diabetes medicines, Ozempic’s primary authorisation is glucose control.

Same active ingredient, different authorisation

Because Wegovy and Ozempic are authorised for different purposes, their prescribing pathways, follow-up expectations, and product positioning differ. For patients, the practical impact is usually: which service you access it through, which pen/dose format is used, and what monitoring is prioritised.

Comparison table (differences that matter)

Feature	Wegovy	Ozempic
Primary authorisation	Weight management (weight loss + maintenance) with diet/activity	Type 2 diabetes management (glucose control)
Typical user intent	Weight loss pathway	Diabetes pathway
Dose structure (high-level)	Weight-management dose escalation to a maintenance dose	Diabetes dosing structure (product-specific)
Access context (UK)	Specialist/NHS pathway (where available) or regulated private weight management service	Diabetes care pathway under clinician management
Most common early effects	Appetite reduction + earlier fullness; GI side effects may occur during escalation	Glucose-related effects; weight change may occur; GI side effects may occur

Dose and escalation: why products feel different

Even though the active ingredient is the same, the way products are packaged and the dose frameworks differ. For weight loss pathways, dose escalation is usually used to build appetite control while reducing side effects.

Which is ‘better for weight loss’?

If your primary goal is weight loss, the most relevant product is usually the one authorised and structured for weight management pathways. What matters more than brand name is eligibility, safe prescribing, tolerability, and consistency with a sustainable diet/activity routine.

Use this decision filter:

If your primary condition is type 2 diabetes: follow your diabetes clinician’s plan.
If your primary goal is weight loss: use a regulated weight management pathway with proper screening.

Safety: side effects and red flags

Because both products contain semaglutide, many side effects overlap especially gastrointestinal symptoms (nausea, diarrhoea, constipation, vomiting), which are more common during dose increases. Side effects are not a measure of success, and severe symptoms require medical review.

UK access: what ‘prescription-only’ means in practice

Both Wegovy and Ozempic are prescription medicines. Safe access means: eligibility screening, medical history review, current medicines review, and appropriate follow-up. Avoid unregulated sellers or social media offers.

Can you switch between Wegovy and Ozempic?

Switching should be clinician-led. Even when the active ingredient is the same, dose formats and titration steps differ. A prescriber can decide whether switching is appropriate and how to transition safely, especially if you’ve had side effects.

Practical choice guide (simple decision tree)

Use this to orient your next step (not as medical advice):

Goal = weight loss → choose a weight management pathway and medication that is authorised/structured for it.
Goal = type 2 diabetes control → follow diabetes pathway under clinician supervision.
Unsure / mixed goals → book a clinician review to align treatment to your main condition and risk profile.